Evidence map›Paper›PMID 42825989›Full record

ArticleFolia microbiologica2026

Global research trends, thematic evolution, and one health implications of ESBL-producing Escherichia coli: a bibliometric and science mapping analysis, 2001-2025.

Cansu Önlen Güneri, Uğur Uğrak, Neslihan Aydemir, Nurnehir Baltaci Bozkurt

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cansu Önlen GüneriDepartment of Medical Laboratory Techniques, Gülhane Vocational School of Health Services, University of Health Sciences, Ankara, Türkiye. cansuonlen@gmail.com.ORCID http://orcid.org/0000-0002-6112-0693
Uğur UğrakDepartment of Health Care Management, Gülhane Vocational School of Health Services, University of Health Sciences, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-6043-835X
Neslihan AydemirDepartment of Medical Laboratory Techniques, Gülhane Vocational School of Health Services, University of Health Sciences, Ankara, Türkiye.ORCID http://orcid.org/0000-0002-7899-0548
Nurnehir Baltaci BozkurtDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0001-7054-8889

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is classified by the World Health Organization (WHO) as a highest-priority pathogen and represents a major threat to modern medicine. This study provides a bibliometric and science-mapping analysis of the global research landscape, intellectual structure, and thematic evolution of ESBL-producing E. coli from 2001 to 2025. A total of 3,483 records retrieved from the Web of Science Core Collection were analyzed using R version 4.6.1 and the Biblioshiny interface 5.0. Performance analysis assessed publication productivity and citation impact. Keyword co-occurrence, thematic mapping, and longitudinal thematic-evolution analyses were used to examine the conceptual structure of the field. The literature showed exponential growth, with an annual growth rate of 28%. Germany, China, and the United States were prominent in the country-level visualizations. Frontiers in Microbiology was the most relevant source. Thematic mapping identified themes related to resistance, prevalence, poultry, and food-producing animals. Thematic evolution showed continuity and changes in emphasis among E. coli, Enterobacteriaceae, antibiotic resistance, and prevalence-related themes. ESBL-producing E. coli research encompasses resistance mechanisms, prevalence, and animal, food, and environmental contexts, with implications for One Health research. ESBL-producing E. coli serves as an indicator organism for examining resistance transmission across the human-animal-environment continuum and for informing One Health strategies. Future research should prioritize integrated molecular surveillance and antimicrobial stewardship interventions across interconnected clinical, animal, food, and environmental reservoirs.

Indexed as

Antimicrobial resistanceBibliometric analysisEscherichia coliExtended-spectrum beta-lactamaseOne healthScience mapping

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.